Pegfilgrastim biosimilar - Gedeon Richter

Drug Profile

Pegfilgrastim biosimilar - Gedeon Richter

Alternative Names: Cavoley - STADA Arzneimittel; Efgratin - Gedeon Richter; Pegylated human granulocyte colony stimulating factor - Gedeon Richter; RGB-02

Latest Information Update: 30 Dec 2016

Price : $50

At a glance

  • Originator Gedeon Richter
  • Class Chemoprotectants; Granulocyte colony-stimulating factors; Polyethylene glycols; Recombinant proteins
  • Mechanism of Action Granulocyte stimulants; Haematopoiesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Submission Withdrawal Neutropenia

Most Recent Events

  • 16 Nov 2016 Regulatory submission withdrawn for Neutropenia in European Union (SC) ,,
  • 08 Dec 2015 Preregistration for Neutropenia in European Union (SC)
  • 08 Apr 2015 Gedeon Richter completes a phase III trial in Neutropenia in Hungary (EudraCT2013-003166-14)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top